Iranian Red Crescent Medical Journal

Published by: Kowsar

Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation

Hormoz Ayromlou 1 , Hassan Soleimanpour 2 , Mehdi Farhoudi 1 , Aliakbar Taheraghdam , Elyar Sadeghi Hokmabadi 1 , * , Rouzbeh Rajaei Ghafouri 2 , Mehdi Najafi Nashali 1 , Ehsan Sharifipour 1 , Somayeh Mostafaei 1 and Davar Altafi 1
Authors Information
1 Department of Neurology, Tabriz University of Medical Sciences, Tabriz, IR Iran
2 Department of Emergency, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: May 5, 2014, 16 (5); e11284
  • Published Online: May 5, 2014
  • Article Type: Research Article
  • Received: April 20, 2013
  • Accepted: April 29, 2013
  • DOI: 10.5812/ircmj.11284

To Cite: Ayromlou H, Soleimanpour H, Farhoudi M, Taheraghdam A, Sadeghi Hokmabadi E, et al. Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation, Iran Red Crescent Med J. 2014 ; 16(5):e11284. doi: 10.5812/ircmj.11284.

Abstract
Copyright © 2014, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussions
Acknowledgements
Footnotes
References
  • 1. Menken M, Munsat TL, Toole JF. The global burden of disease study: implications for neurology. Arch Neurol. 2000; 57(3): 418-20[PubMed]
  • 2. WHo . The global burden of disease. 2004;
  • 3. Jauch EC, Cucchiara B, Adeoye O, Meurer W, Brice J, Chan YY, et al. Part 11: adult stroke: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010; 122(18 Suppl 3)-28[DOI][PubMed]
  • 4. O'Rourke KE, Walsh CD, Kelly PJ. Safety and efficacy of IV-TPA for ischaemic stroke in clinical practice--a Bayesian analysis. Cerebrovasc Dis. 2009; 28(6): 572-81[DOI][PubMed]
  • 5. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004; 363(9411): 768-74[DOI][PubMed]
  • 6. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet. 2010; 375(9727): 1695-703[DOI][PubMed]
  • 7. Hosseini AA, Sobhani-Rad D, Ghandehari K, Benamer HT. Frequency and clinical patterns of stroke in Iran - Systematic and critical review. BMC Neurol. 2010; 10: 72[DOI][PubMed]
  • 8. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006; 367(9524): 1747-57[DOI][PubMed]
  • 9. Suwanwela NC, Phanthumchinda K, Likitjaroen Y. Thrombolytic therapy in acute ischemic stroke in Asia: The first prospective evaluation. Clin Neurol Neurosurg. 2006; 108(6): 549-52[DOI][PubMed]
  • 10. Ghandehari K, Zahed AP, Taheri M, Abbasi M, Gorjestani S, Ahmadi AM, et al. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA. Int J Stroke. 2009; 4(4): 236[DOI][PubMed]
  • 11. Nguyen TH, Truong AL, Ngo MB, Bui CT, Dinh QV, Doan TC, et al. Patients with thrombolysed stroke in Vietnam have an excellent outcome: results from the Vietnam Thrombolysis Registry. Eur J Neurol. 2010; 17(9): 1188-92[DOI][PubMed]
  • 12. De Silva DA, Yassin N, Toh AJ, Lim DJ, Wong WX, Woon FP, et al. Timing of arrival to a tertiary hospital after acute ischaemic stroke - A follow-up survey 5 years later. Ann Acad Med Singapore. 2010; 39(7): 513-5[PubMed]
  • 13. Durai Pandian J, Padma V, Vijaya P, Sylaja PN, Murthy JM. Stroke and thrombolysis in developing countries. Int J Stroke. 2007; 2(1): 17-26[DOI][PubMed]
  • 14. Wasay M, Barohi H, Malik A, Yousuf A, Awan S, Kamal AK. Utilization and outcome of thrombolytic therapy for acute stroke in Pakistan. Neurol Sci. 2010; 31(2): 223-5[DOI][PubMed]
  • 15. Naess H, Waje-Andreassen U, Brogger J, Thomassen L. [Patients with acute cerebral infarction admitted to stroke unit]. Tidsskr Nor Laegeforen. 2011; 131(8): 814-8[DOI][PubMed]
  • 16. Sung SF, Ong CT, Wu CS, Hsu YC, Su YH. Increased use of thrombolytic therapy and shortening of in-hospital delays following acute ischemic stroke: experience on the establishment of a primary stroke center at a community hospital. Acta Neurol Taiwan. 2010; 19(4): 246-52[PubMed]
  • 17. Sharma SR, Sharma N. Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: feasibility and effectivity from an Indian perspective. Ann Indian Acad Neurol. 2008; 11(4): 221-4[DOI][PubMed]
  • 18. Hatcher MA, Starr JA. Role of tissue plasminogen activator in acute ischemic stroke. Ann Pharmacother. 2011; 45(3): 364-71[DOI][PubMed]
  • 19. Padma MV, Singh MB, Bhatia R, Srivastava A, Tripathi M, Shukla G, et al. Hyperacute thrombolysis with IV rtPA of acute ischemic stroke: efficacy and safety profile of 54 patients at a tertiary referral center in a developing country. Neurol India. 2007; 55(1): 46-9[PubMed]
  • 20. Nandigam K, Narayan SK, Elangovan S, Dutta TK, Sethuraman KR, Das AK. Feasibility of acute thrombolytic therapy for stroke. Neurol India. 2003; 51(4): 470-3[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments